Polypill with or without Aspirin in Persons without Cardiovascular Disease.
Salim YusufPhilip JosephAntonio DansPeggy GaoKoon TeoDenis XavierPatricio López-JaramilloKhalid YusoffAnwar SantosoHabib GamraShamim TalukderCourtney ChristouPreeti GirishKaren YeatesFreeda XavierGilles DagenaisCatalina RochaTara McCreadyJessica TyrwhittJacqueline BoschPrem Paisnull nullPublished in: The New England journal of medicine (2020)
Combined treatment with a polypill plus aspirin led to a lower incidence of cardiovascular events than did placebo among participants without cardiovascular disease who were at intermediate cardiovascular risk. (Funded by the Wellcome Trust and others; TIPS-3 ClinicalTrials.gov number, NCT01646437.).